Table 2 Clinical characteristics of patients with pancreatic cancer in two treatment groups from the FAERS database
Characteristics (n = 8253) | Gemcitabine | Gemcitabine combined with albumin-bound paclitaxel |
|---|---|---|
Number of reports, n(%) | 3987 (48.3) | 4266 (51.7) |
Gender, n(%) | Â | Â |
Male | 1474 (37.0) | 2307 (54.1) |
Female | 1129 (28.3) | 1722 (40.4) |
Missing | 1384 (34.7) | 237 (5.6) |
Age (years), n(%) | Â | Â |
Median (IQR) | 66 (59–73) | 67 (59–72) |
< 18 | 11 (0.2) | 6 (0.1) |
18–64 | 1084 (27.2) | 1531 (35.9) |
≥ 65 | 1398 (35.1) | 2172 (50.9) |
Missing | 1494 (37.5) | 557 (13.1) |
Weight (kg), n(%) | Â | Â |
Median (IQR) | 65 (56.8–78) | 68 (58–79) |
< 50 | 66 (1.7) | 209 (4.9) |
50–100 | 671 (16.8) | 1666 (39.1) |
> 100 | 36 (0.9) | 85 (2.0) |
Missing | 3214 (80.6) | 2306 (54.1) |
Reporter, n(%) | Â | Â |
Consumer | 582 (14.6) | 376 (8.8) |
Health Professional | 685 (17.2) | 542 (12.7) |
Physician | 1103 (27.7) | 1740 (40.8) |
Other Professional | 1406 (35.3) | 1395 (32.7) |
Pharmacist | 162 (4.1) | 202 (4.7) |
Missing | 49 (1.2) | 11 (0.3) |